Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Long-Term Safety and Efficacy Study of Botaretigene Sparoparvovec for Patients with X-Linked Retinitis Pigmentosa

    Not recruiting

    3 1 1 1
    Belgium Denmark France Italy The Netherlands Spain
  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +13
  • Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland Germany +7
  • Study on Oral Glibenclamide for Managing High Blood Sugar in Premature Infants Weighing Less Than 1500g

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Nanatinostat and Valganciclovir for Patients with Epstein-Barr Virus-Positive Relapsed or Refractory Lymphomas

    Not recruiting

    2 1 1 1
    France Germany Italy Spain
  • Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia Denmark France Germany +10
  • Study on R3R01 for Patients with Alport Syndrome and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Germany The Netherlands
  • Study on Radiotherapy with Nimotuzumab and Vinorelbine for Newly Diagnosed Childhood and Adolescent Diffuse Intrinsic Pontine Glioma (DIPG) Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Finland France Germany Hungary Italy +4
  • Study on Health, Activity, and Joint Outcomes in Patients Aged 13-69 with Severe or Moderate Hemophilia A Using Emicizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Germany Hungary Italy Spain